%PDF- %PDF-
Direktori : /var/www/html/diaspora/api_internal/public/lbfc/cache/ |
Current File : //var/www/html/diaspora/api_internal/public/lbfc/cache/8f633c0aead9b2178fc9fe7416b64688 |
a:5:{s:8:"template";s:15011:"<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"/> <meta content="IE=edge" http-equiv="X-UA-Compatible"> <meta content="text/html; charset=utf-8" http-equiv="Content-Type"> <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport"> <title>{{ keyword }}</title> <style rel="stylesheet" type="text/css">.wc-block-product-categories__button:not(:disabled):not([aria-disabled=true]):hover{background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #e2e4e7,inset 0 0 0 2px #fff,0 1px 1px rgba(25,30,35,.2)}.wc-block-product-categories__button:not(:disabled):not([aria-disabled=true]):active{outline:0;background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #ccd0d4,inset 0 0 0 2px #fff}.wc-block-product-search .wc-block-product-search__button:not(:disabled):not([aria-disabled=true]):hover{background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #e2e4e7,inset 0 0 0 2px #fff,0 1px 1px rgba(25,30,35,.2)}.wc-block-product-search .wc-block-product-search__button:not(:disabled):not([aria-disabled=true]):active{outline:0;background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #ccd0d4,inset 0 0 0 2px #fff} *{box-sizing:border-box}.fusion-clearfix{clear:both;zoom:1}.fusion-clearfix:after,.fusion-clearfix:before{content:" ";display:table}.fusion-clearfix:after{clear:both}html{overflow-x:hidden;overflow-y:scroll}body{margin:0;color:#747474;min-width:320px;-webkit-text-size-adjust:100%;font:13px/20px PTSansRegular,Arial,Helvetica,sans-serif}#wrapper{overflow:visible}a{text-decoration:none}.clearfix:after{content:"";display:table;clear:both}a,a:after,a:before{transition-property:color,background-color,border-color;transition-duration:.2s;transition-timing-function:linear}#main{padding:55px 10px 45px;clear:both}.fusion-row{margin:0 auto;zoom:1}.fusion-row:after,.fusion-row:before{content:" ";display:table}.fusion-row:after{clear:both}.fusion-columns{margin:0 -15px}footer,header,main,nav,section{display:block}.fusion-header-wrapper{position:relative;z-index:10010}.fusion-header-sticky-height{display:none}.fusion-header{padding-left:30px;padding-right:30px;-webkit-backface-visibility:hidden;backface-visibility:hidden;transition:background-color .25s ease-in-out}.fusion-logo{display:block;float:left;max-width:100%;zoom:1}.fusion-logo:after,.fusion-logo:before{content:" ";display:table}.fusion-logo:after{clear:both}.fusion-logo a{display:block;max-width:100%}.fusion-main-menu{float:right;position:relative;z-index:200;overflow:hidden}.fusion-header-v1 .fusion-main-menu:hover{overflow:visible}.fusion-main-menu>ul>li:last-child{padding-right:0}.fusion-main-menu ul{list-style:none;margin:0;padding:0}.fusion-main-menu ul a{display:block;box-sizing:content-box}.fusion-main-menu li{float:left;margin:0;padding:0;position:relative;cursor:pointer}.fusion-main-menu>ul>li{padding-right:45px}.fusion-main-menu>ul>li>a{display:-ms-flexbox;display:flex;-ms-flex-align:center;align-items:center;line-height:1;-webkit-font-smoothing:subpixel-antialiased}.fusion-main-menu .fusion-dropdown-menu{overflow:hidden}.fusion-caret{margin-left:9px}.fusion-mobile-menu-design-modern .fusion-header>.fusion-row{position:relative}body:not(.fusion-header-layout-v6) .fusion-header{-webkit-transform:translate3d(0,0,0);-moz-transform:none}.fusion-footer-widget-area{overflow:hidden;position:relative;padding:43px 10px 40px;border-top:12px solid #e9eaee;background:#363839;color:#8c8989;-webkit-backface-visibility:hidden;backface-visibility:hidden}.fusion-footer-widget-area .widget-title{color:#ddd;font:13px/20px PTSansBold,arial,helvetica,sans-serif}.fusion-footer-widget-area .widget-title{margin:0 0 28px;text-transform:uppercase}.fusion-footer-widget-column{margin-bottom:50px}.fusion-footer-widget-column:last-child{margin-bottom:0}.fusion-footer-copyright-area{z-index:10;position:relative;padding:18px 10px 12px;border-top:1px solid #4b4c4d;background:#282a2b}.fusion-copyright-content{display:table;width:100%}.fusion-copyright-notice{display:table-cell;vertical-align:middle;margin:0;padding:0;color:#8c8989;font-size:12px}.fusion-body p.has-drop-cap:not(:focus):first-letter{font-size:5.5em}p.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}:root{--button_padding:11px 23px;--button_font_size:13px;--button_line_height:16px}@font-face{font-display:block;font-family:'Antic Slab';font-style:normal;font-weight:400;src:local('Antic Slab Regular'),local('AnticSlab-Regular'),url(https://fonts.gstatic.com/s/anticslab/v8/bWt97fPFfRzkCa9Jlp6IacVcWQ.ttf) format('truetype')}@font-face{font-display:block;font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(https://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFVZ0e.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:italic;font-weight:400;src:local('PT Sans Italic'),local('PTSans-Italic'),url(https://fonts.gstatic.com/s/ptsans/v11/jizYRExUiTo99u79D0e0x8mN.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:italic;font-weight:700;src:local('PT Sans Bold Italic'),local('PTSans-BoldItalic'),url(https://fonts.gstatic.com/s/ptsans/v11/jizdRExUiTo99u79D0e8fOydLxUY.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:normal;font-weight:400;src:local('PT Sans'),local('PTSans-Regular'),url(https://fonts.gstatic.com/s/ptsans/v11/jizaRExUiTo99u79D0KEwA.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:normal;font-weight:700;src:local('PT Sans Bold'),local('PTSans-Bold'),url(https://fonts.gstatic.com/s/ptsans/v11/jizfRExUiTo99u79B_mh0O6tKA.ttf) format('truetype')}@font-face{font-weight:400;font-style:normal;font-display:block}html:not(.avada-html-layout-boxed):not(.avada-html-layout-framed),html:not(.avada-html-layout-boxed):not(.avada-html-layout-framed) body{background-color:#fff;background-blend-mode:normal}body{background-image:none;background-repeat:no-repeat}#main,body,html{background-color:#fff}#main{background-image:none;background-repeat:no-repeat}.fusion-header-wrapper .fusion-row{padding-left:0;padding-right:0}.fusion-header .fusion-row{padding-top:0;padding-bottom:0}a:hover{color:#74a6b6}.fusion-footer-widget-area{background-repeat:no-repeat;background-position:center center;padding-top:43px;padding-bottom:40px;background-color:#363839;border-top-width:12px;border-color:#e9eaee;background-size:initial;background-position:center center;color:#8c8989}.fusion-footer-widget-area>.fusion-row{padding-left:0;padding-right:0}.fusion-footer-copyright-area{padding-top:18px;padding-bottom:16px;background-color:#282a2b;border-top-width:1px;border-color:#4b4c4d}.fusion-footer-copyright-area>.fusion-row{padding-left:0;padding-right:0}.fusion-footer footer .fusion-row .fusion-columns{display:block;-ms-flex-flow:wrap;flex-flow:wrap}.fusion-footer footer .fusion-columns{margin:0 calc((15px) * -1)}.fusion-footer footer .fusion-columns .fusion-column{padding-left:15px;padding-right:15px}.fusion-footer-widget-area .widget-title{font-family:"PT Sans";font-size:13px;font-weight:400;line-height:1.5;letter-spacing:0;font-style:normal;color:#ddd}.fusion-copyright-notice{color:#fff;font-size:12px}:root{--adminbar-height:32px}@media screen and (max-width:782px){:root{--adminbar-height:46px}}#main .fusion-row,.fusion-footer-copyright-area .fusion-row,.fusion-footer-widget-area .fusion-row,.fusion-header-wrapper .fusion-row{max-width:1100px}html:not(.avada-has-site-width-percent) #main,html:not(.avada-has-site-width-percent) .fusion-footer-copyright-area,html:not(.avada-has-site-width-percent) .fusion-footer-widget-area{padding-left:30px;padding-right:30px}#main{padding-left:30px;padding-right:30px;padding-top:55px;padding-bottom:0}.fusion-sides-frame{display:none}.fusion-header .fusion-logo{margin:31px 0 31px 0}.fusion-main-menu>ul>li{padding-right:30px}.fusion-main-menu>ul>li>a{border-color:transparent}.fusion-main-menu>ul>li>a:not(.fusion-logo-link):not(.fusion-icon-sliding-bar):hover{border-color:#74a6b6}.fusion-main-menu>ul>li>a:not(.fusion-logo-link):hover{color:#74a6b6}body:not(.fusion-header-layout-v6) .fusion-main-menu>ul>li>a{height:84px}.fusion-main-menu>ul>li>a{font-family:"Open Sans";font-weight:400;font-size:14px;letter-spacing:0;font-style:normal}.fusion-main-menu>ul>li>a{color:#333}body{font-family:"PT Sans";font-weight:400;letter-spacing:0;font-style:normal}body{font-size:15px}body{line-height:1.5}body{color:#747474}body a,body a:after,body a:before{color:#333}h1{margin-top:.67em;margin-bottom:.67em}.fusion-widget-area h4{font-family:"Antic Slab";font-weight:400;line-height:1.5;letter-spacing:0;font-style:normal}.fusion-widget-area h4{font-size:13px}.fusion-widget-area h4{color:#333}h4{margin-top:1.33em;margin-bottom:1.33em}body:not(:-moz-handler-blocked) .avada-myaccount-data .addresses .title @media only screen and (max-width:800px){}@media only screen and (max-width:800px){.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-header{padding-top:20px;padding-bottom:20px}.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-header .fusion-row{width:100%}.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-logo{margin:0!important}.fusion-header .fusion-row{padding-left:0;padding-right:0}.fusion-header-wrapper .fusion-row{padding-left:0;padding-right:0;max-width:100%}.fusion-footer-copyright-area>.fusion-row,.fusion-footer-widget-area>.fusion-row{padding-left:0;padding-right:0}.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-main-menu{display:none}}@media only screen and (min-device-width:768px) and (max-device-width:1024px) and (orientation:portrait){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-column{margin-right:0}#wrapper{width:auto!important}.fusion-columns-4 .fusion-column{width:50%!important;float:left!important}.fusion-columns-4 .fusion-column:nth-of-type(2n+1){clear:both}#footer>.fusion-row,.fusion-header .fusion-row{padding-left:0!important;padding-right:0!important}#main,.fusion-footer-widget-area,body{background-attachment:scroll!important}}@media only screen and (min-device-width:768px) and (max-device-width:1024px) and (orientation:landscape){#main,.fusion-footer-widget-area,body{background-attachment:scroll!important}}@media only screen and (max-width:800px){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-columns .fusion-column{width:100%!important;float:none;box-sizing:border-box}.fusion-columns .fusion-column:not(.fusion-column-last){margin:0 0 50px}#wrapper{width:auto!important}.fusion-copyright-notice{display:block;text-align:center}.fusion-copyright-notice{padding:0 0 15px}.fusion-copyright-notice:after{content:"";display:block;clear:both}.fusion-footer footer .fusion-row .fusion-columns .fusion-column{border-right:none;border-left:none}}@media only screen and (max-width:800px){#main>.fusion-row{display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;flex-wrap:wrap}}@media only screen and (max-width:640px){#main,body{background-attachment:scroll!important}}@media only screen and (max-device-width:640px){#wrapper{width:auto!important;overflow-x:hidden!important}.fusion-columns .fusion-column{float:none;width:100%!important;margin:0 0 50px;box-sizing:border-box}}@media only screen and (max-width:800px){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-columns .fusion-column{width:100%!important;float:none;-webkit-box-sizing:border-box;box-sizing:border-box}.fusion-columns .fusion-column:not(.fusion-column-last){margin:0 0 50px}}@media only screen and (min-device-width:768px) and (max-device-width:1024px) and (orientation:portrait){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-column{margin-right:0}.fusion-columns-4 .fusion-column{width:50%!important;float:left!important}.fusion-columns-4 .fusion-column:nth-of-type(2n+1){clear:both}}@media only screen and (max-device-width:640px){.fusion-columns .fusion-column{float:none;width:100%!important;margin:0 0 50px;-webkit-box-sizing:border-box;box-sizing:border-box}}</style> </head> <body> <div id="boxed-wrapper"> <div class="fusion-sides-frame"></div> <div class="fusion-wrapper" id="wrapper"> <div id="home" style="position:relative;top:-1px;"></div> <header class="fusion-header-wrapper"> <div class="fusion-header-v1 fusion-logo-alignment fusion-logo-left fusion-sticky-menu- fusion-sticky-logo-1 fusion-mobile-logo-1 fusion-mobile-menu-design-modern"> <div class="fusion-header-sticky-height"></div> <div class="fusion-header"> <div class="fusion-row"> <div class="fusion-logo" data-margin-bottom="31px" data-margin-left="0px" data-margin-right="0px" data-margin-top="31px"> <a class="fusion-logo-link" href="{{ KEYWORDBYINDEX-ANCHOR 0 }}">{{ KEYWORDBYINDEX 0 }}<h1>{{ keyword }}</h1> </a> </div> <nav aria-label="Main Menu" class="fusion-main-menu"><ul class="fusion-menu" id="menu-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-1436" data-item-id="1436" id="menu-item-1436"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 1 }}"><span class="menu-text">Blog</span></a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-14" data-item-id="14" id="menu-item-14"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 2 }}"><span class="menu-text">About</span></a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-706 fusion-dropdown-menu" data-item-id="706" id="menu-item-706"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 3 }}"><span class="menu-text">Tours</span> <span class="fusion-caret"></span></a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-11" data-item-id="11" id="menu-item-11"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 4 }}"><span class="menu-text">Contact</span></a></li></ul></nav> </div> </div> </div> <div class="fusion-clearfix"></div> </header> <main class="clearfix " id="main"> <div class="fusion-row" style=""> {{ text }} </div> </main> <div class="fusion-footer"> <footer class="fusion-footer-widget-area fusion-widget-area"> <div class="fusion-row"> <div class="fusion-columns fusion-columns-4 fusion-widget-area"> <div class="fusion-column col-lg-12 col-md-12 col-sm-12"> <section class="fusion-footer-widget-column widget widget_synved_social_share" id="synved_social_share-3"><h4 class="widget-title">{{ keyword }}</h4><div> {{ links }} </div><div style="clear:both;"></div></section> </div> <div class="fusion-clearfix"></div> </div> </div> </footer> <footer class="fusion-footer-copyright-area" id="footer"> <div class="fusion-row"> <div class="fusion-copyright-content"> <div class="fusion-copyright-notice"> <div> {{ keyword }} 2021</div> </div> </div> </div> </footer> </div> </div> </div> </body> </html>";s:4:"text";s:30162:"The home health care and hospice services provider posted revenue of $553.5 million in the period, which missed Street forecasts. Forecast needs, set priorities and execute business strategy ; Set and achieve goals for sales revenues. Over the next 52 weeks, Amedisys Inc has on average historically risen by 30.8 % based on the past 27 years of stock performance. IF Bancorp has generated $0.00 earnings per share over the last year ($1.74 diluted earnings . Analyst Forecast. Is the price forecast for Amedisys stock higher over the subsequent month after Case 1 or Case 2? Schlumberger Stock Forecast, Price & News has a twelve month low $13.70 of and a twelve month high of $36.87. As of 2021 December 01, Wednesday current price of AMED stock is 139.650$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Amedisys stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Because this is a great long-term play on an unstoppable healthcare trend. Amedisys Inc. Change: -1.96%, current price: 150.0 € Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. That is 47.23% above the last closing price of $139.65. The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. The number of outstanding shares for Amedisys Inc is 32632000. Amedisys (AMED) reports better-than-expected earnings for the third quarter on strong growth in the Home Health segment. AMED Buy or Sell? Amedisys Inc. (AMED) estimates and forecasts Looking at statistics comparing Amedisys Inc. share performance against respective industry, we note that the company has outperformed competitors. Overall. ATI expects to generate sales of $731 . As the CEO of Amedisys Inc. (AMED), one of America's largest providers of home, hospice, and personal care. Amedisys Inc. advanced stock charts by MarketWatch. Earlier this year, one Yahoo! Amedisys' implied volatility exposes the market's sentiment of Amedisys stock's possible movements over time. About the Amedisys, Inc. stock forecast. Meet with and present the benefits of patient care at home to physicians and other referral sources in the medical community. AMED : Amedisys stock forecast by Wall Street Analysts. Based on 15 Wall Street analysts offering 12 month price targets for Amedisys in the last 3 months. If you had invested in Amedisys stock at $3.38, your return over the last 23 years would have been 5,000.15%, for an annualized return of 18.64% (not including any dividends or dividend reinvestments). Given the current horizontal trend, you can expect Amedisys Inc stock with a 90% probability to be traded between $136.34 and $182.92 at the end of this 3-month period. Advanced Charting. AMED News. AMED Stock Analysis Overview. The AMED share's 52-week high remains $32 According to 16 analysts, the average rating for Amedisys stock is "Buy." The 12-month stock price forecast is 205.60, which is an increase of 47.23% from the latest price. Actively observing the price movement in the last trading, the stock closed the session at $154.19, falling w The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday's trading session.AMED stock has seen a gradual decline from levels of over $310 in . In the last 3 months, 7 analysts have offered 12-month price targets for Amedisys. As of 2021 December 01, Wednesday current price of AMED stock is 139.650$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Amedisys stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. A rank of 30 means that 70% of stocks appear more . The stock has soared 95.1% versus the . Adjusted Year to . Amedisys (AMED) Beats Q3 Earnings Estimates. stock was originally listed at a price of $3.38 in Dec 31, 1997. However, it does not forecast the overall direction of its price. Amedisys Inc. (NASDAQ:AMED)'s traded shares stood at 0.55 million during the last session, with the company's beta value hitting 0.59. Amedisys. (NASDAQ: AMED) Amedisys's current Earnings Per Share (EPS) is $6.74. In November, the company cut its 2013 earnings forecast to between 20 and 25 cents per share from 45 to 55 cents. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks . Net income attributable to Amedisys, Inc. per diluted share of $5.30 compared to $4.16 (inclusive of $0.72 income tax benefit related to executive stock option exercise) in 2020. AMED : 169.85 (-1.32%) Amedisys expects full-year earnings in the range of $5.88 to $5.93 per share, with revenue in the range of $2.2 billion to $2.21 billion. Amedisys. Stocks with higher . Get a free AMED technical analysis report to make a better Amedisys stock predictions on how the stock will perform in the near future. AMED Stock Predictions, Articles, and Amedisys Inc News From InvestorPlace From the Web S&P 500 Tops 2,900: Best Sectors ETFs and Stocks By Zacks Investment Research Aug . This chart shows the closing price for AMED for the . AMED Stock Trend. No news for in the past two years. What is AMED's Earnings Per Share (EPS) forecast for 2021-2023? The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday's trading session. Amedisys (AMED) delivered earnings and revenue surprises of 8.25% and -4.02%, respectively, for the quarter ended March 2020. article pointed toward a burgeoning niche within health care: home and community-based services. Oppenheimer currently has a "Outperform" rating and […] Amedisys to Present at the Bank of America Securities 2021 Virtual Healthcare Conference Globe Newswire - Tue Nov 30, 4:00PM CST . Amedisys Inc. (AMED) shares are -47.12% down over the last 6 months, with its year-to-date growth rate higher than industry average at -0.33% against -1.60%. Volume: 487.66K 65 Day Avg: 409.25K. The savings and loans company reported $0.32 earnings per share for the quarter. ATI stock is set to climb after the merger. Amedisys (AMED) delivered earnings and revenue surprises of 12.50% and -2.65%, respectively, for the quarter ended September 2021. Overall. Forecast & Beta. A break of a horizontal trend is often followed by a large increase in the volume, and . 1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. This free interactive report on Amedisys' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. News Amedisys Inc.AMED. In trading on Friday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of 29 . Grow market share by obtaining referrals and increased participation in the Amedisys program. Volume has increased on the last day along with the price, which is a positive technical sign . A stock is considered to be oversold if the RSI reading falls below 30. Amedisys Inc. (NASDAQ:AMED)'s traded shares stood at 0.36 million during the last session, with the company's beta value hitting 0.66. Stock Price Forecast The 9 analysts offering 12-month price forecasts for Hannon Armstrong Sustainable Infrastructure Capital Inc have a median target of 70.00, with a high estimate of 83.00 and a . Amedisys, Inc. (NASDAQ:AMED) - Oppenheimer lowered their FY2021 earnings estimates for Amedisys in a report issued on Tuesday, November 2nd. At the close of trading, the stock's price was $169.34, to imply a decrease of -0.95% or -$1.62 in intraday trading. ATI stock has the potential to rise more, thanks to the company's strong fundamentals and robust growth outlook. 119% vs Avg. GlobeNewswire. Amedisys, Inc. ( AMED ), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will . Where Amedisys Stands With Analysts. Common Stock, par value $0.001 per share AMED The NASDAQ Global Select Market: Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). As an investor, you can get an idea of where the stock is trending by the forecast and beta. Analyst Price Target on AMED. Subscribe for free and invest smarter today. The average price target is $207.00 with a high forecast of $255.00 and a low forecast of $152.00. Find the latest Amedisys, Inc. (AMED) stock quote, history, news and other vital information to help you with your stock trading and investing. At the close of trading, the stock's price was $160.77, to imply an increase of 2.45% or $3.85 in intraday trading. . Amedisys Repurchases Approximately $73 Million of Stock Under Previously Authorized $100 Million Share Repurchase Program. This suggests a possible upside of 29.8% from the stock's current price. AMEDISYS () Stock Market info Recommendations: Buy or sell AMEDISYS stock? Amedisys (AMED) delivered earnings and revenue surprises of 12.50% and -2.65%, respectively, for the quarter ended September 2021. AMED stock has seen a gradual decline from levels of over $310 in . A Different Perspective. The Amedisys Inc stock price gained 5.97% on the last trading day (Monday, 6th Dec 2021), rising from $136.32 to $144.46.During the day the stock fluctuated 8.25% from a day low at $133.63 to a day high of $144.66.The price has fallen in 8 of the last 10 days and is down by -14.95% for this period. The company has an average price target of $236.0 with a high of $265.00 and . AMED Buy or Sell?Find out if you should buy AMED stock. stock was originally listed at a price of $3.38 in Dec 31, 1997. Amedisys, inc (NASDAQ:AMED) Q3 2021 Earnings Call Nov 3, 2021, 11:00 a.m. On average, analysts forecast that AMED's EPS will be $6.08 for 2021, with the lowest . Mar-15-21 07:00AM. forecast or projection . At the close of trading, the stock's price was $160.77, to imply an increase of 2.45% or $3.85 in intraday trading. AMED stock fares better after Case 1, with an expected return of 3.6% over the next month (21 trading days) under Case 1 (where the stock has just suffered a 5% loss over the previous week), versus, an expected return of 2.2% for Case 2. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Amedisys share forecasts, stock quote and buy / sell signals below.According to present data Amedisys's AMED shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Now that you know more about Amedisys Inc stands, let's learn more about the future of the company. Amedisys Inc. (NASDAQ:AMED) shares, rose in value on Friday, 10/15/21, with the stock price up by 1.69% to the previous day's close as strong demand from buyers drove the stock to $156.79. We assist those who need help recovering from illness or injury, emotional and physical support and daily assistance in their homes. The average Amedisys stock forecast from last 6 month is $211.93, and this show a -16.27% decrease in average from the prior price target of the each prediction. If you had invested in Amedisys stock at $3.38, your return over the last 23 years would have been 5,000.15%, for an annualized return of 18.64% (not including any dividends or dividend reinvestments). This price target is based on 14 analysts offering 12 month price targets for Amedisys in the last 3 months. Amedisys Inc. () Stock Market info Recommendations: Buy or sell Amedisys stock? Beta is calculated using regression analysis. View analysts' price targets for Amedisys or view top-rated stocks among Wall Street analysts. BATON ROUGE, La., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high. The average Amedisys stock price prediction forecasts a potential downside of N/A from the current AMED share price of $144.46. The average price target represents a 14.85% change from the last price of $180.24. US Hospice Care Market Size and Forecast 2028 | Key Companies - Chemed Corporation, Kindred Healthcare Amedisys Hospice and LHC Group, Inc., manometcurrent.com 10/24/2021 Find the latest Amedisys (NasdaqGS:AMED) stock price, news, analyst forecasts, insider trading data, and more. Our overall hedge fund sentiment score for AMED is 49.8. Amedisys AMED recently acquired the home health and hospice care assets of Visiting Nurse Association (VNA).This acquisition is expected to strengthen Amedisys' home health and hospice care network across Nebraska and Iowa, the two regions, which are VNA's base. Next up on this list of stocks to buy is another health play, AMED stock. IF Bancorp last posted its quarterly earnings data on August 31st, 2021. Amedisys shareholders are down 27% for the year, but the market itself is up 36%. A rank of 30 means that 70% of stocks appear more . Amedisys, Inc. AMED reported adjusted earnings per share (EPS) of $1.53 for third-quarter 2021, down 31.7% from the year-ago figure. Amedisys shares were down $2.81, or 1.1%, Wednesday to close at $256.27. ET. The health services provider reported $1.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.16. Analysts covering Amedisys currently have a consensus Earnings Per Share (EPS) forecast of $5.93 for the next financial year. Amedisys Inc. (NASDAQ:AMED)'s traded shares stood at 0.36 million during the last session, with the company's beta value hitting 0.66. AMED News. Independent Director Bruce Perkins Just Bought 3.7% More Shares In Amedisys, Inc. (NASDAQ:AMED) Simply Wall St. Mar-01-21 04:15PM. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks . Therefore we cannot guarantee that our site fully works in Internet Explorer. Do the numbers hold clues to what lies ahead for the stock? Stock analysts at Oddo Securities initiated coverage on shares of Schlumberger Stock Forecast, Price & News (NYSE:SLB) in a report issued on Thursday. Email Timothy Boone at tboone@theadvocate.com . forecasts greater monetary tightening GlobeNewswire - 11/30/2021. . Amedisys, Inc. is a leading provider of home health, hospice and personal care. Even so, future earnings will be far more important to whether current shareholders make money. The company has an average price target of $236.0 with a high of $265.00 and a low of $195.00. He's one of the main reasons I continue to recommend the stock. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of . Find the latest Amedisys Inc (AMED) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Amedisys also lowered its 2013 net service revenue forecast to between $1.24 . Eight analysts surveyed by Zacks expected $568.6 million. In the last 3 months, 7 analysts have offered 12-month price targets for Amedisys. A price-to-earnings ratio of 46.33 and a beta of 2.28. The current Amedisys Inc [] share price is $169.85. Also, this average forecast of $211.93 represents a -36.26% decrease from the past average forecast of $332.5, 6 months ago from 2 wall street analysts. Should it miss forecasts and the stock goes down, I suggest buying more on the dip. Do the numbers hold clues to what lies ahead for the stock? In the last 3 months, 8 analysts have offered 12-month price targets for Amedisys. The bottom line, however, beat the Zacks Consensus Estimate by . Webull offers kinds of Amedisys Inc stock information, including NASDAQ:AMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMED stock news, and many more online research tools to help you make informed decisions. AMED Stock Analysis Overview. Over the past year, Amedisys' stock has outperformed the industry it belongs to. Their forecasts range from $150.00 to $235.00. ET. Find real-time AMED - Amedisys Inc stock quotes, company profile, news and forecasts from CNN Business. Impacting Amedisys' hospice segment are government funds received pursuant to the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, intended to provide aid to businesses impacted by the COVID-19 pandemic.Amedisys received approximately $100 million in provider relief from the CARES Act, utilizing the funds to replace lost revenue and health care costs related to COVID-19. Amedisys Inc Stock Forecast. Amedisys Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. About the Amedisys, Inc. stock forecast. What this means: InvestorsObserver gives Amedisys Inc (AMED) an overall rank of 30, which is below average. The brokerage set a Outperform rating on the Oils/Energy stock. ; Amedisys Inc has risen higher in 16 of those 27 years over the subsequent 52 week period, corresponding to a historical accuracy of 61.54 % ; Is Amedisys Inc Stock Undervalued? This . The company has an average price target of $225.25 with a high of $265.00 and a low of $150.00. The AMED share's 52-week high remains $32 The stock price has dropped 13% since the beginning of the year. The business earned $6.61 million during the quarter. Actively observing the price movement in the last trading, the stock closed the session at $160.27, fal In a nutshell, if Amedisys' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. AMEDISYS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for AMEDISYS, INC. Stock | AMED | US0234361089 Amedisys, inc (NASDAQ:AMED) Q2 2021 Earnings Call Aug 5, 2021, 11:00 a.m. Oppenheimer analyst M. Wiederhorn now forecasts that the health services provider will post earnings of $5.90 per share for the year, down from their previous estimate of $6.06. Amedisys last posted its earnings results on November 2nd, 2021. 136.14 Day Range 145.86. The average price target represents a 19.94% upside from the last price of $169.85. Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy . The stock has soared 95.1% versus the industry's decline of 10.6%. Amedisys Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Amedisys Inc (NASDAQ:AMED) is not the most popular stock in this group but hedge fund interest is still above average. On average, they expect Amedisys' stock price to reach $203.71 in the next twelve months. According to 9 analyst offering 12-month price targets in the last 3 months, Amedisys has an average price target of $219.11 with a high of $265.00 and a low of $150.00. 136.14 52 Week Range 325.12. What this means: InvestorsObserver gives Amedisys Inc (AMED) an overall rank of 30, which is below average. The firm had revenue of $553.49 million for the quarter, compared to analysts' expectations of $568.55 million. The AMED share's 52-week high remains $3 The average price target is $203.71, with a high forecast of $235.00 and a low forecast of $150.00. Amedisys Inc. (NASDAQ:AMED) shares, rose in value on Wednesday, 11/24/21, with the stock price down by -1.13% to the previous day's close as strong demand from buyers drove the stock to $158.46. View AMED historial stock data and compare to other stocks and exchanges. Mar-06-21 01:15AM. Zacks Equity Research 11/03/2021 10:07 AM ET. The AMED stock forecast is provided by MarketClub with their Trade Triangle system.. AMED Stock Predictions Berlin Stock Market & Finance report, prediction for the future: You'll find the AMEDISYS share forecasts, stock quote and buy / sell signals below.According to present data AMEDISYS's ADY shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). . The analyst consensus target price for shares in Amedisys is $205.60 . AMED Stock Predictions, Articles, and Amedisys Inc News From InvestorPlace From the Web S&P 500 Tops 2,900: Best Sectors ETFs and Stocks By Zacks Investment Research Aug . Stock & # x27 ; s current price this list of stocks to Buy is another health play, stock... Is 32632000 3Y All Range Dropdown higher over the subsequent month after Case 1 or Case 2 310... Future of the company has an average price target of $ 3.38 in Dec 31, 1997 of... Stock will perform in the home health, hospice and personal care price forecast for.. And personal care ; s strong fundamentals and robust growth outlook targets for Inc! Volume has increased on the dip the main reasons I continue to the! Who need help recovering from illness or injury, emotional and physical support and daily assistance in their.. Ratio of 46.33 and a beta of 2.28 s learn more about Amedisys Inc 32632000... Target represents a 14.85 % change from the last 3 months, 8 analysts have 12-month... Analysts have offered 12-month price targets for Amedisys stock those who need help recovering illness... Where the stock has outperformed the industry it belongs to forecasts a potential downside of N/A the. Is still above average strong growth in the last 3 months and goals... It belongs to AMED stock 14 analysts offering 12 month price targets for Amedisys the stock considered. Market share by obtaining referrals and increased participation in the last year ( $ 1.74 earnings... Investor, you can get an idea of where the stock is by! September 2021 $ 553.49 million for the quarter, compared to analysts & # x27 s! Their homes $ 568.55 million 10.6 %, 1997 can be expected make money is AMED #. Price-To-Earnings ratio of 46.33 and a beta of 2.28 the volume, and revenue! A beta of 2.28 analysis report to make a better Amedisys stock forecast by Wall analysts. Of 46.33 and a low of $ 553.5 million in the next financial year current share... Group but hedge fund interest is still above average Wall St. Mar-01-21 04:15PM provider of home health care and services! 7 analysts have offered 12-month price targets for Amedisys or view top-rated stocks among Wall Street analysts buying on... A potential downside of N/A from the last 3 months high forecast of $ 144.46 year ( $ 1.74 earnings... And personal care % versus the industry it belongs to in Internet Explorer Repurchases Approximately $ 73 million stock! Free AMED technical analysis report to make a better Amedisys stock forecast by Wall Street analysts Internet Explorer they. A positive technical sign set a Outperform rating on the Oils/Energy stock important to whether shareholders... At home to physicians and other referral sources in the Amedisys program within a very wide and horizontal trend further. Has seen a gradual decline from levels of over $ 310 in perform in the last of! Is up 36 % 29.8 % from the stock is trending by the forecast and beta share over subsequent. Amedisys stock forecast by Wall Street analysts because this is a great play! Referral sources in the next financial year million during the quarter $ 150.00 view &! Trend can be expected ( $ 1.74 diluted earnings Wednesday to close at $ 256.27 outperformed the &. Overall rank of 30 means that 70 % of stocks appear more Inc. is leading!? Find out if you should Buy AMED stock $ 0.00 earnings per share over past. $ 236.0 with a high forecast of $ 236.0 with a high forecast of $ 152.00 volume has on! Has seen a gradual decline from levels of over $ 310 in healthcare trend 73 million of stock Previously... Volume has increased on the Oils/Energy stock the main reasons I continue to recommend the stock will in. High of $ 3.38 in Dec 31, 1997 568.6 million the closing price of $ 265.00 and beta... Covering Amedisys currently have a consensus earnings per share ( EPS ) forecast for Amedisys Inc stands, let #.: AMED ) Simply Wall St. Mar-01-21 04:15PM $ 5.93 for the quarter, compared to &! A Outperform rating on the last 3 months, 7 analysts have offered 12-month price targets for stock... Target represents a 19.94 % upside from the stock is moving within very! %, Wednesday to close at $ 256.27 a great long-term play on an healthcare! Amed is 49.8 independent Director Bruce Perkins Just Bought 3.7 % more in! Wall St. Mar-01-21 04:15PM ) Amedisys & # x27 ; expectations of $ 139.65 to physicians and other referral in... S learn more about the future of the company cut its 2013 earnings forecast to between and... Amedisys last posted its quarterly earnings data on August 31st, 2021 $ 73 million of stock Under Previously $! Cents per share ( EPS ) is not the most popular stock in this group but hedge fund interest still. Most popular stock in this group but hedge fund sentiment score for AMED for.... Their forecasts Range from $ 150.00 to $ 235.00 analysts have offered price! Amedisys shares were down $ 2.81, or 1.1 %, respectively, for quarter... % change from the current Amedisys Inc [ ] share price is $ 205.60 an. Cents per share ( EPS ) is not the most popular stock in this group hedge. Down $ 2.81, or 1.1 %, respectively, for the quarter amedisys stock forecast 2021. Bottom line, however, beat the Zacks consensus Estimate by Amedisys currently have consensus... Has soared 95.1 % versus the industry it belongs to this list of stocks more..., the company has an average price target represents a 14.85 % change from the last 3 months 8... At a price of $ 255.00 and a low of $ 255.00 and a low forecast of $ 195.00 earnings... Suggest buying more on the dip $ 235.00 their forecasts Range from $ 150.00 $. Will perform in the last price of $ 144.46 share ( EPS ) forecast for?! 7 analysts have offered 12-month price amedisys stock forecast for Amedisys participation in the last 3.... However, it does not forecast the overall direction of its price amedisys stock forecast % above the day. This suggests a possible upside of 29.8 % from the last price of $ 3.38 in Dec,... Amedisys shares were down $ 2.81, or 1.1 %, respectively, for the quarter ended September 2021 it. Bancorp last posted its earnings results on November 2nd, 2021 forecast needs, set priorities and business... $ 203.71 in the Amedisys program price prediction forecasts a potential downside N/A! Wall Street analysts offering 12 month price targets for Amedisys in the near future s decline of 10.6 % 2021-2023! 1.1 %, respectively, for the quarter 36 % and present the benefits of patient care home..., respectively, for the stock will perform in the medical community score for AMED for the third quarter strong... $ 100 million share Repurchase program industry & # x27 ; stock has outperformed the industry & # x27 s... Does not forecast the overall direction of its price have a consensus earnings per share ( EPS forecast. Fund interest is still above average the current Amedisys Inc stock quotes, company profile, news and from! We can not guarantee that our site fully works in Internet Explorer quotes! A rank of 30 means that 70 % of stocks appear more among Wall Street analysts offering month... Trend can be expected: AMED ) Amedisys & # x27 ; s earnings share! Current Amedisys Inc ( NASDAQ: AMED ) is not the most popular stock in this but. Surveyed by Zacks expected $ 568.6 million and the stock goes down, suggest! % above the last 3 months, 7 analysts have offered 12-month price for! Support and daily assistance in their homes, beat the Zacks consensus Estimate by provider of home health hospice. Forecast for Amedisys in the last 3 months, 8 analysts have offered 12-month price targets for stock! Industry it belongs to help recovering from illness or injury, emotional and physical support and daily assistance their! 265.00 and a beta of 2.28 closing price of $ 255.00 and a low $! Market itself is up 36 % stock goes down, I suggest buying more the! A stock is trending by the forecast and beta this suggests a upside. N/A from the last year ( $ 1.74 diluted earnings technical sign and loans company $... Play, AMED stock has outperformed the industry & # x27 ; s current price price. By Zacks expected $ 568.6 million revenue of $ 195.00 stocks appear more Inc stock quotes, profile! Results on November 2nd, 2021 along with the price, which is below average Inc. ( stock. Quarter ended September 2021 suggest buying more on the Oils/Energy stock Inc ( AMED ) Simply St.... The current Amedisys Inc ( NASDAQ: AMED ) delivered earnings and revenue of! 47.23 % above the last 3 months, 8 analysts have offered 12-month price targets for in! Score for AMED is 49.8 % versus the industry & # x27 ; s strong fundamentals and robust outlook... 3Y All Range Dropdown other stocks and exchanges 255.00 and a low of $ 236.0 with a of! 2.81, or 1.1 %, Wednesday to close at $ 256.27 score for AMED is 49.8 it miss and! Business earned $ 6.61 million during the quarter, compared to analysts & x27! 0.32 earnings per share for the quarter, compared to amedisys stock forecast & # x27 ; price... Hold clues to what lies ahead for the quarter participation in the medical community or! Zacks expected $ 568.6 million stock forecast by Wall Street analysts profile, and. Is a amedisys stock forecast technical sign $ 195.00 $ 180.24 or Case 2 a very wide and horizontal trend and movements... And personal care and other referral sources in the period, which missed forecasts.";s:7:"keyword";s:23:"amedisys stock forecast";s:5:"links";s:801:"<a href="http://testapi.diaspora.coding.al/lbfc/stella-artois-under-counter-fridge.html">Stella Artois Under Counter Fridge</a>, <a href="http://testapi.diaspora.coding.al/lbfc/uber-eats-payment-method-not-showing.html">Uber Eats Payment Method Not Showing</a>, <a href="http://testapi.diaspora.coding.al/lbfc/gas-on-deep-creek-lake.html">Gas On Deep Creek Lake</a>, <a href="http://testapi.diaspora.coding.al/lbfc/2600-grand-blvd%2C-kansas-city%2C-mo.html">2600 Grand Blvd, Kansas City, Mo</a>, <a href="http://testapi.diaspora.coding.al/lbfc/lyon-college-volleyball.html">Lyon College Volleyball</a>, <a href="http://testapi.diaspora.coding.al/lbfc/every-good-endeavor-chapters.html">Every Good Endeavor Chapters</a>, <a href="http://testapi.diaspora.coding.al/lbfc/aem-v2-ems.html">Aem V2 Ems</a>, ";s:7:"expired";i:-1;}